Home › Alexion gets EU approval for drug acquired in Synageva deal
 

Keywords :   


Alexion gets EU approval for drug acquired in Synageva deal

2015-09-02 03:25:24| Biotech - Topix.net

Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease. European health regulators approved Kanuma for patients with lysosomal acid lipase deficiency .

Tags: in deal drug approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.07Eastern North Pacific Tropical Weather Outlook
08.07Atlantic Tropical Weather Outlook
08.07Tropical Storm Beryl Potential Storm Surge Flooding Map
07.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
07.07Tropical Storm Beryl Graphics
07.07Tropical Storm Beryl Forecast Discussion Number 37
07.07Tropical Storm Beryl Storm Surge Watch/Warning Map
07.07Tropical Storm Beryl Wind Speed Probabilities Number 37
More »